VIVUS Inc.
1172 Castro Street
Mountain View,
CA 94040
United States - Map
Phone: 650-934-5200
Fax: 650-934-5379
Web Site: http://www.vivus.com
| VIVUS, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic products for underserved markets in the United States. The company offers MUSE, a minimally invasive therapy for erectile dysfunction. It develops drug candidates that address the need of obesity, diabetes, and sexual health markets. The companys late-stage clinical products, which are under development, include Qnexa that is in phase 3 clinical trials for obesity and completed phase 2 clinical trials for diabetes; Avanafil, which is in phase 3 studies to treat erectile dysfunction; and Luramist, for which the phase 2 study is completed for the treatment of hypoactive sexual desire disorder in women. It has a development, licensing, and supply agreement with Tanabe Seiyaku Co., Ltd. for the development of Avanafil; and licensing agreements with Acrux and its subsidiary to develop and, if approved, commercialize Luramist and Evamist in the United States. The company was founded in 1991 and is headquartered in Mountain View, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Leland F. Wilson , 64
Chief Exec. Officer |
$
734.00K |
$
375.00K | Mr. Peter Y. Tam , 45
Pres |
$
396.00K |
$
68.00K | Dr. Virgil A. Place M.D., 84
Founder, Chief Scientific Officer |
N/A
| N/A | Mr. Tim Morris CPA, 47
Chief Financial Officer and VP of Fin. |
N/A
| N/A | Mr. Guy P. Marsh , 55
VP of U S Operations and Gen. Mang. |
$
353.00K |
$
837.00K |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.29% Nasdaq 
Profile
